Ari Raved, Director at AIT Therapeutics, Inc. (AITB), sold 74,000 shares at $3.20 ($237K) on 2018-06-22, disclosed to the SEC on 2018-06-27.
Open-market sale of $237k AITB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.